The Asian Age

Ci­pla un­veils drug in Ger­many

- — PTI

New Delhi: Phar­ma­ceu­ti­cal ma­jor Ci­pla on Mon­day launched its generic drug used for treat­ment of asthma and chronic ob­struc­tive pul­monary dis­ease in Ger­many and Swe­den. While the drug Sal­me­terol/ Flu­ti­ca­s­one MDI will be sold un­der the Ser­roflo brand in Ger­many, it will be mar­keted as Sal­me­terol/ Flu­ti­ca­s­one Ci­pla in Swe­den, Ci­pla stated. Com­ment­ing on the de­vel­op­ment, Ci­pla Europe head Frank Pi­eters said, “With Ser­roflo we of­fer in Ger­many and Swe­den an al­ter­na­tive which is ef­fec­tive and ef­fi­cient and there­fore brings many ad­van­tages.”

Newspapers in English

Newspapers from India